Chrome Extension
WeChat Mini Program
Use on ChatGLM

Trial in Progress: A Phase 1 Trial of TSC-100 and TSC-101, Engineered T Cell Therapies That Target Minor Histocompatibility Antigens to Eliminate Residual Disease after Hematopoietic Cell Transplantation

MOLECULAR THERAPY(2024)

Cited 0|Views0
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined